Searching for tumor cells in fluid for recurrent meningioma
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This study looks for tumor cells in your blood or spinal fluid to see if they can help track aggressive meningiomas that have come back. It may help doctors understand your cancer better and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had surgery for a grade 2 or 3 meningioma at Montpellier University Hospital between 2015 and 2024.
- Your original tumor showed a protein called SSTR2A.
- Your meningioma has come back or grown, as seen on an MRI scan.
- You do not have any other active cancer.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at tiny particles called extracellular vesicles in the blood of people with meningioma, a type of brain tumor. The goal is to learn more about these particles and how they relate to the tumor, which may help in understanding the disease better.
This study uses a special PET scan to see if your recurrent meningioma has a protein called PSMA. This could help decide if a new treatment that targets this protein might work for you.
This trial uses a special PET scan to find active tumor areas and then delivers a stronger dose of radiation to those spots. It is for people with aggressive or returning meningiomas who have not had brain radiation before.
This trial studies whether changes in RNA (the instructions inside cells) can help doctors better diagnose and treat gliomas, a type of brain tumor. If you are scheduled for surgery to remove a suspected glioma and have not had prior treatment, you may be able to join.
This study collects samples of spinal fluid and blood from people with solid tumours that have spread to the brain or spine, or who have primary brain tumours. The goal is see if these samples can help doctors detect and monitor these cancers more easily.
This study looks at how solid tumors spread to the lining of the brain and spinal cord. It aims to understand this condition better by reviewing patient records.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.